AKT1 and Hyperglycemia: The above results show that the augmentation of ΙRβ activity, binding to IRS, and subsequent IRS tyrosine phosphorylation by C646 leads to the activation of PI3K-AKT signaling and the suppression of glucose production in the liver and alleviation of hyperglycemia.